Palvella Therapeutics to Report Q3 Results, Highlight Progress in Rare Skin Disease Trials
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced it will report third-quarter 2025 financial results before markets open on Tuesday, November 11, 2025. Company leadership will host a live …
Palvella Therapeutics to Report Q3 Results, Highlight Progress in Rare Skin Disease Trials Read More